Fitzgerald Thomas A 4
4 · Transcode Therapeutics, Inc. · Filed Jun 18, 2024
Insider Transaction Report
Form 4
Fitzgerald Thomas A
DirectorVP, Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-06-14+650,000→ 650,000 totalExercise: $1.20Exp: 2034-06-13→ Common Stock (650,000 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the shares subject to this option vested and became exercisable on January 1, 2024, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.